The Burden of Lower Limb Deformities in Low- and Lower-Middle-Income Countries: A Scoping Review Authors: Rachel L. Montoya, Kehinde S. Agoro, Riasoya Jodah, Sanjeev Sabharwal, Coleen S. Sabatini Published: 2026 ABSTRACT Musculoskeletal (MSK) conditions like lower limb deformities significantly contribute to the global burden of disease. Low-income countries (LICs) and lower-middle-income countries (LMICs) are disproportionately affected, yet specifics surrounding MSK conditions in these regions remain largely unquantified. This scoping review seeks to (1) assess the epidemiologic information currently available for lower limb deformities in LICs and LMICs, including etiology and treatment, as well as (2) examine the individual, societal, and socioeconomic impact of these conditions. A scoping review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines searched PubMed, Embase, and Web of Science databases for studies published between 2012 and 2022 in LICs and LMICs containing statistics and epidemiological data quantifying the prevalence of lower limb deformities and/or providing sociological or economic analysis of the burden of those deformities. Forty-two studies of the original 3476 screened were included in this review. The studies, spanning 51 different LICs and LMICs, were primarily cross-sectional (n = 19) in design. Most studies had level IV evidence (n = 27, 64%). Trauma was the most common reported etiology of lower limb deformity (60%), clubfoot the most often reported congenital condition (75%), and amputation the most common reported treatment (67%). Less than half of included studies (n = 18, 43%) investigated disease burden utilizing either quality-adjusted life years or disability-adjusted life years, employment level, functional outcomes, psychological/interpersonal impact, and/or access to care. Despite the high prevalence of lower limb deformities in LICs and LMICs, associated epidemiological and disease burden data remain limited. Available studies broadly categorized sequelae of MSK injuries with limited information on treatment outcomes. Amputation was the most commonly mentioned surgical treatment despite the potential societal stigma regarding amputees. Even fewer studies explored the burden of MSK conditions impacting quality of life. A deeper understanding of the prevalence and impact of specific MSK conditions in LICs and LMICs will provide actionable data to inform a more comprehensive, locally relevant, and sustainable approach to managing lower limb deformities in resource-challenged environments.Key Concepts(1)Lower limb deformities from a variety of congenital and acquired etiologies can impact patients from birth, including their physical and psychosocial well-being and function in society.(2)Lower limb deformities are especially impactful in the setting of low-income countries (LICs)/lower-middle-income countries (LMICs) where adaptive, surgical, and prosthetic options can be limited, and there is a dearth of data on the exact epidemiology of these deformities that limits the ability to calculate specific prevalence or incidence by country.(3)More granular and standardized data collection and distribution is needed on the epidemiology and burden of lower limb deformities in LICs/LMICs in order to inform policies aimed at increasing access to care, preventing, and treating such deformities as well as to better allow for analysis and quantification of the burden of disease on a socioeconomic and individual level. Introduction Over 5 billion people worldwide lack access to safe and affordable surgical care, with the greatest need in low-income countries (LICs) and lower-middle-income countries (LMICs), where an additional 143 million surgical procedures annually are required in an attempt to lower mortality rates and prevent disability [1]. Encouragingly, findings over the past decade suggest that countries with lower sociodemographic indices have made significant progress over the past decade, highlighting the potential for sustainable health improvements with appropriate health care investments [2]. The impact of musculoskeletal (MSK) conditions, including lower limb deformities (LLD) and resultant secondary disabilities, on the global burden of disease is widely recognized. This impact continues to rise, with disability accounting for an increasing proportion of the overall burden [[2], [3], [4]]. MSK conditions are a critical factor in driving this increasing burden, contributing to a 30.7% rise in age-standardized disability-adjusted life year (DALY) rates from 1990 to 2019, mainly affecting LICs and LMICs [2]. Among MSK pathologies, lower limb deformities can be uniquely limiting to people’s daily level of function, often impeding the ability to ambulate, perform activities of daily living, and be gainfully employed. From congenital deformities to those acquired after birth as sequelae of trauma, infection, or cancer, these deformities substantially impact individuals’ physical and mental health from childhood onward, often subjecting them and their caretakers to psychosocial stigma. In LICs and LMICs, where many are employed in agricultural jobs or survive on subsistence farming, such limb deformities have repercussions not just beyond the affected individual but also at a macroscopic level when such conditions prevent individuals from supporting their families and local communities. From a policy and development perspective, epidemiologic data thoroughly quantifying the prevalence and incidence of lower limb deformities is an essential first step in allocating resources toward developing effective interventions to prevent and treat such deformities. To augment such data, an informed perspective of the breadth of the “burden of disease” of such deformities requires understanding the financial, sociopolitical, and mental health costs experienced by patients with these MSK conditions and the downstream impact on their families and communities. In this study, we sought to evaluate the available published epidemiology of lower limb deformities in LICs and LMICs. Furthermore, we planned to review the available qualitative and quantitative data on the impact of such deformities on patient function and well-being at the individual level and, if available, the burden of disease at the societal level. Methodology A scoping review was conducted to determine the epidemiology and all-encompassing burden of lower limb deformities in LICs and LMICs, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines [5]. Inclusion and exclusion criteria Inclusion criteria captured relevant studies over 10 years (2012–2022) reporting on some aspect of epidemiology, including the prevalence of lower limb deformities caused by any infectious, traumatic, congenital, nutritional, oncologic, or other pathology in pediatric and/or adult patients from countries classified as LICs or LMICs by the World Bank as of April 2022 while excluding studies exclusively from high-income countries (HICs) and upper-middle-income countries unless such studies included data regarding patients displaced or emigrated from LICs or LMICs receiving care in neighboring nations with higher classification economies. For the purposes of the study, deformities were defined as congenital or acquired lower limb pathologies, malformations, or abnormalities in patients with otherwise normal brains and spinal cords. Beyond epidemiologic data, we also included studies reporting on quantitative aspects of the broader socioeconomic and patient-reported burden of disease of lower limb deformities in LICs and LMICs, such as DALYs and/or quality-adjusted life years (QALYs) or qualitative aspects via patient-reported outcome (PRO) measures. We excluded studies solely in high-income nation settings looking only at patients from those nations, focused solely on upper limb deformities, and those which included only acute fractures without long-term follow-up or data on eventual post-traumatic deformity. We also excluded studies focused on conditions related to diabetes as the prevention and management is primarily medical and endocrine rather than orthopaedic. Studies focused on the sequelae of MSK injuries in military personnel of HICs while deployed in LICs and LMICs were also excluded. Databases and search terms We designed the search strategy in collaboration with a medical librarian to capture relevant studies on lower limb deformities and their burden in LICs and/or LMICs through the lens of epidemiology and socioeconomic impact analyses. PubMed (https://pubmed.ncbi.nlm.nih.gov/), Embase (https://www.embase.com/search/quick), and Web of Science (https://webofknowledge.com) databases were queried using a predetermined structure incorporating comprehensive search terms capturing the epidemiology of congenital, traumatic, infectious, oncologic, and nutritionally acquired MSK deformities. Twenty-eight LICs and 44 LMICs based on the World Bank classifications by income level in 2022 were incorporated into search queries (Appendix 1). References of relevant articles were also reviewed to identify other potential studies. Selection and screening process Using the aforementioned eligibility criteria, two reviewers (R.M. and K.A.) independently assessed identified articles through screening titles and abstracts (Fig. 1). After this initial screening process, selected articles from the first round underwent full-text reviews by three reviewers (R.M., K.A., and R.J.). The two senior authors, fellowship-trained orthopaedic surgeons (C.S. and S.S.), resolved reviewer discrepancies. The reviewers were not blinded to the journal or the authors associated with the articles.Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. Data extraction Three reviewers (R.M., K.A., and R.J.) extracted data independently from the selected studies uploaded into Covidence (Melbourne, Australia) using a standardized data abstraction form (Appendix 2) to collect relevant article information. This included study setting and geographic location based on the World Bank region classification, population demographics, study aim, study design/methodology, level of evidence based on Journal of Bone and Joint Surgery classification [6], etiology, diagnosis, anatomic location, treatment, epidemiology, burden of disease, and author conclusions. Results Based on the inclusion criteria, we identified 42 eligible studies (Fig. 1) [[7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]]. Of these, 19 (45%) were cross-sectional in design (Table 1), seven were retrospective cohort studies (17%) (Table 2), and five were case series (12%) (Table 3).Table 1Description of included cross-sectional studies.Table 1SourceLocationNo. of participants with specified LLDAge range (years) of the entire sample% male in the entire sampleAnatomic location of lower limb deformity (foot and ankle, long bone, both, other)Modality of burden of disease described (QALY/DALY, employment, function, behavioral)Abbey et al. (2017) [12]Nigeria4NeonatesNABothNot describedAbich et al. (2020) [48]Ethiopia14511–1543Foot and ankleNot describedAlves et al. (2018) [10]Uganda24820–18NABoth, otherNot describedChalya et al. (2012) [41]Tanzania1402–7568BothNot describedChawla et al. (2016) [40]Nepal5835.5∗63BothBehavioralElliott et al. (2015) [37]Sierra Leone1410–10046BothNot describedFahal et al. (2015) [35]Sudan57233–8876BothNot describedIbrahim et al. (2013) [32]Pakistan410–551BothNot describedJones et al. (2015) [31]Gambia360.5–1852BothNot describedMaine et al. (2017) [28]Rwanda45–5044Foot and ankleNot describedMosleh et al. (2018) [26]Palestine940–6025BothNot describedNgoie et al. (2021) [24]Malawi1020–6049BothBehavioralNizamli et al. (2020) [25]Syria6520–60100BothBehavioral, employmentOluwafemi et al. (2019) [22]Nigeria5Neonates41BothNot describedOwen et al. (2018) [21]Afghanistan, etc.†24,4360–15NAFoot and ankleNot describedSilesh et al. (2021) [7]Ethiopia25Neonates60Foot and ankleNot describedSmythe et al. (2017) [17]Cameroon100-80+40.8BothFunctionTchirkov et al. (2012) [15]Guinea19310–6870BothEmployment, functionUruc et al. (2014) [14]Syria941–9089BothNot describedDALY, disability-adjusted life year; QALY, quality-adjusted life year.∗Median age, age range was provided in categories of <14, 14–65, and 65+ years old.†Afghanistan, Burkina Faso, Burundi, DRC, Eritrea, Ethiopia, Guinea-Bissau, Liberia, Madagascar, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, Sudan, Tanzania, Togo, Uganda, Haiti, Vietnam, Solomon Islands, Nigeria, Nicaragua, Lao, Kenya, India, Honduras, Ghana, El Salvador, Egypt, Cameroon, Cabo Verde, Bangladesh, Nepal, Zimbabwe, Zambia.Table 2Description of included cohort studies.Table 2SourceStudy typeLocationNo. of participants with specified LLDAge range (years) of the entire sample% Male of the entire sampleAnatomic location of lower limb deformity (foot and ankle, long bone, both, other)Modality of burden of disease described (QALY/DALY, employment, function, behavioral)Alves et al. (2018) [11]RetrospectiveUganda20470–1855OtherNot describedBarth et al. (2021) [44]RetrospectiveAfghanistan, Cambodia, Myanmar, Sudan26,862∗0–6085BothNot describedBertani et al. (2015) [43]RetrospectiveAfghanistan80–1677BothNot describedBraithwaite et al. (2016)ProspectiveMalawi423–1567BothBehavioral, functionDhillon et al. (2022) [39]RetrospectiveIndia3381–7585BothNot describedEze et al. (2012) [36]ProspectiveNigeria44†NA59BothNot describedGrudziak et al. (2019) [34]RetrospectiveMalawi48439‡71BothNot describedKironde et al. (2019) [9]ProspectiveUganda2230.8‡81Long boneNot describedMonsereenusorn et al. (2022) [27]RetrospectivePhilippines475–1854Long boneNot describedNoor et al. (2014) [23]RetrospectiveCambodia255–4727Long boneBehavioralSethurman et al. (2021) [19]ProspectiveIndia7818–8890Long boneBehavioral, employment, function,QALY/DALYLLD, lower limb deformity; DALY, disability-adjusted life year; QALY, quality-adjusted life year.∗This count also included deformities from participants in Iraq, as distribution by country was unavailable.†This count includes upper limb deformities as prevalence was not separated by anatomic region.‡This is the mean age of the sample; the age range was unavailable.Table 3Description of included case series, case-control, economic, and qualitative studies.Table 3SourceStudy typeLocationNo. of participants with specified LLDAge range (years) of the entire sample% male of the entire sampleAnatomic location of lower limb deformity (foot and ankle, long bone, both)Modality of burden of disease described (QALY/DALY, employment, function, behavioral)Acoglu et al. (2020) [47]Case seriesSyria220–259BothNot describedAjibade et al. (2013) [46]Case seriesNigeria9814–4686BothNot describedAndregård et al. (2017) [45]QualitativeSierra Leone1227–4175Long boneBehavioral, employmentEkwochi et al. (2018) [38]Case-controlNigeria15Neonates59BothNot describedHabib et al. (2015) [33]Economic evaluationBenin, etc.∗5454†NANABothQALY/DALYMagnusson et al. (2019) [29]Case-controlIndia15515–6051BothBehavioralMactaggart et al. (2019) [30]Case-controlMyanmar10818–6089BothBehavioral, employment, functionRattray et al. (2013) [8]Economic evaluationCambodia4NANAFoot and ankleQALY/DALYRoberts et al. (2016) [20]Economic evaluationZambia23NA35Long boneQALY/DALYSiddiqui et al. (2015) [18]Case seriesIndia105–6861BothBehavioralTatar et al. (2021) [16]Case seriesSyria2616–8687BothEmploymentWeyhee et al. (2019) [13]Case seriesLiberia969–9173BothNot describedLLD, lower limb deformity; DALY, disability-adjusted life year; QALY, quality-adjusted life year.∗Burkina Faso, Cameroon, Chad, Cote d'Ivoire, Gambia, Ghana, Guinea, Guinea Bissau, Liberia, Niger, Nigeria, Senegal, Sierra Leone, Togo.†This includes deformities of upper limbs as there was no stratification by anatomic location. Table 1Description of included cross-sectional studies.Table 1SourceLocationNo. of participants with specified LLDAge range (years) of the entire sample% male in the entire sampleAnatomic location of lower limb deformity (foot and ankle, long bone, both, other)Modality of burden of disease described (QALY/DALY, employment, function, behavioral)Abbey et al. (2017) [12]Nigeria4NeonatesNABothNot describedAbich et al. (2020) [48]Ethiopia14511–1543Foot and ankleNot describedAlves et al. (2018) [10]Uganda24820–18NABoth, otherNot describedChalya et al. (2012) [41]Tanzania1402–7568BothNot describedChawla et al. (2016) [40]Nepal5835.5∗63BothBehavioralElliott et al. (2015) [37]Sierra Leone1410–10046BothNot describedFahal et al. (2015) [35]Sudan57233–8876BothNot describedIbrahim et al. (2013) [32]Pakistan410–551BothNot describedJones et al. (2015) [31]Gambia360.5–1852BothNot describedMaine et al. (2017) [28]Rwanda45–5044Foot and ankleNot describedMosleh et al. (2018) [26]Palestine940–6025BothNot describedNgoie et al. (2021) [24]Malawi1020–6049BothBehavioralNizamli et al. (2020) [25]Syria6520–60100BothBehavioral, employmentOluwafemi et al. (2019) [22]Nigeria5Neonates41BothNot describedOwen et al. (2018) [21]Afghanistan, etc.†24,4360–15NAFoot and ankleNot describedSilesh et al. (2021) [7]Ethiopia25Neonates60Foot and ankleNot describedSmythe et al. (2017) [17]Cameroon100-80+40.8BothFunctionTchirkov et al. (2012) [15]Guinea19310–6870BothEmployment, functionUruc et al. (2014) [14]Syria941–9089BothNot describedDALY, disability-adjusted life year; QALY, quality-adjusted life year.∗Median age, age range was provided in categories of <14, 14–65, and 65+ years old.†Afghanistan, Burkina Faso, Burundi, DRC, Eritrea, Ethiopia, Guinea-Bissau, Liberia, Madagascar, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, Sudan, Tanzania, Togo, Uganda, Haiti, Vietnam, Solomon Islands, Nigeria, Nicaragua, Lao, Kenya, India, Honduras, Ghana, El Salvador, Egypt, Cameroon, Cabo Verde, Bangladesh, Nepal, Zimbabwe, Zambia. Description of included cross-sectional studies. DALY, disability-adjusted life year; QALY, quality-adjusted life year. Median age, age range was provided in categories of <14, 14–65, and 65+ years old. Afghanistan, Burkina Faso, Burundi, DRC, Eritrea, Ethiopia, Guinea-Bissau, Liberia, Madagascar, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, Sudan, Tanzania, Togo, Uganda, Haiti, Vietnam, Solomon Islands, Nigeria, Nicaragua, Lao, Kenya, India, Honduras, Ghana, El Salvador, Egypt, Cameroon, Cabo Verde, Bangladesh, Nepal, Zimbabwe, Zambia. Table 2Description of included cohort studies.Table 2SourceStudy typeLocationNo. of participants with specified LLDAge range (years) of the entire sample% Male of the entire sampleAnatomic location of lower limb deformity (foot and ankle, long bone, both, other)Modality of burden of disease described (QALY/DALY, employment, function, behavioral)Alves et al. (2018) [11]RetrospectiveUganda20470–1855OtherNot describedBarth et al. (2021) [44]RetrospectiveAfghanistan, Cambodia, Myanmar, Sudan26,862∗0–6085BothNot describedBertani et al. (2015) [43]RetrospectiveAfghanistan80–1677BothNot describedBraithwaite et al. (2016)ProspectiveMalawi423–1567BothBehavioral, functionDhillon et al. (2022) [39]RetrospectiveIndia3381–7585BothNot describedEze et al. (2012) [36]ProspectiveNigeria44†NA59BothNot describedGrudziak et al. (2019) [34]RetrospectiveMalawi48439‡71BothNot describedKironde et al. (2019) [9]ProspectiveUganda2230.8‡81Long boneNot describedMonsereenusorn et al. (2022) [27]RetrospectivePhilippines475–1854Long boneNot describedNoor et al. (2014) [23]RetrospectiveCambodia255–4727Long boneBehavioralSethurman et al. (2021) [19]ProspectiveIndia7818–8890Long boneBehavioral, employment, function,QALY/DALYLLD, lower limb deformity; DALY, disability-adjusted life year; QALY, quality-adjusted life year.∗This count also included deformities from participants in Iraq, as distribution by country was unavailable.†This count includes upper limb deformities as prevalence was not separated by anatomic region.‡This is the mean age of the sample; the age range was unavailable. Description of included cohort studies. LLD, lower limb deformity; DALY, disability-adjusted life year; QALY, quality-adjusted life year. This count also included deformities from participants in Iraq, as distribution by country was unavailable. This count includes upper limb deformities as prevalence was not separated by anatomic region. This is the mean age of the sample; the age range was unavailable. Table 3Description of included case series, case-control, economic, and qualitative studies.Table 3SourceStudy typeLocationNo. of participants with specified LLDAge range (years) of the entire sample% male of the entire sampleAnatomic location of lower limb deformity (foot and ankle, long bone, both)Modality of burden of disease described (QALY/DALY, employment, function, behavioral)Acoglu et al. (2020) [47]Case seriesSyria220–259BothNot describedAjibade et al. (2013) [46]Case seriesNigeria9814–4686BothNot describedAndregård et al. (2017) [45]QualitativeSierra Leone1227–4175Long boneBehavioral, employmentEkwochi et al. (2018) [38]Case-controlNigeria15Neonates59BothNot describedHabib et al. (2015) [33]Economic evaluationBenin, etc.∗5454†NANABothQALY/DALYMagnusson et al. (2019) [29]Case-controlIndia15515–6051BothBehavioralMactaggart et al. (2019) [30]Case-controlMyanmar10818–6089BothBehavioral, employment, functionRattray et al. (2013) [8]Economic evaluationCambodia4NANAFoot and ankleQALY/DALYRoberts et al. (2016) [20]Economic evaluationZambia23NA35Long boneQALY/DALYSiddiqui et al. (2015) [18]Case seriesIndia105–6861BothBehavioralTatar et al. (2021) [16]Case seriesSyria2616–8687BothEmploymentWeyhee et al. (2019) [13]Case seriesLiberia969–9173BothNot describedLLD, lower limb deformity; DALY, disability-adjusted life year; QALY, quality-adjusted life year.∗Burkina Faso, Cameroon, Chad, Cote d'Ivoire, Gambia, Ghana, Guinea, Guinea Bissau, Liberia, Niger, Nigeria, Senegal, Sierra Leone, Togo.†This includes deformities of upper limbs as there was no stratification by anatomic location. Description of included case series, case-control, economic, and qualitative studies. LLD, lower limb deformity; DALY, disability-adjusted life year; QALY, quality-adjusted life year. Burkina Faso, Cameroon, Chad, Cote d'Ivoire, Gambia, Ghana, Guinea, Guinea Bissau, Liberia, Niger, Nigeria, Senegal, Sierra Leone, Togo. This includes deformities of upper limbs as there was no stratification by anatomic location. Forty-one of these studies could be rated using the JBJS Level of Evidence criteria, including 2 (5%) level II, 12 (29%) level III, and 27 (64%) level IV studies. One remaining study was qualitative [45], scoring 7/10 on the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Qualitative Research (JBI, 2017) (Fig. 2) [49].Figure 2Distribution of studies by study design and level of evidence. LOE, level of evidence. Distribution of studies by study design and level of evidence. LOE, level of evidence. The studies represented 51 different LICs and LMICs, the majority from sub-Saharan Africa (n = 33), followed by East Asia and the Pacific (n = 6), South Asia (n = 5), Latin America and the Caribbean (n = 4), and the Middle East and North Africa (n = 3) (Fig. 3). Studies overwhelmingly focused on a single area within each country, with 10% of studies spanning multiple countries.Figure 3Global distribution of countries represented by eligible studies based on World Bank income-level classification (as of April 2022). Global distribution of countries represented by eligible studies based on World Bank income-level classification (as of April 2022). Where demographic information was provided, male and female participants were typically included, with only one study excluding female participants. Overall, 57.1% of studies included children and adults. In contrast, 35.7% targeted the pediatric population exclusively (Fig. 4).Figure 4Age and sex demographics across all participants in included studies, which included participants with differences other than lower limb differences due to limited categorization by etiology. Age and sex demographics across all participants in included studies, which included participants with differences other than lower limb differences due to limited categorization by etiology. The most frequently reported etiology for lower limb deformity was trauma (60%), followed by congenital deformities (38%). Among traumatic etiologies, deformities were mostly secondary to road traffic injuries (32%) or war/conflict (28%). Clubfoot was the most commonly reported congenital lower limb deformity (75%) (Fig. 5).Figure 5Distribution of lower limb deformity across included studies by etiology. Distribution of lower limb deformity across included studies by etiology. The treatment rendered for the limb deformity was reported in 64% of the included studies. Lower limb amputation was the most common (67%) surgical procedure reported following development of acquired deformities secondary to noncongenital etiologies, such as traumatic, oncologic, or infectious causes. Several authors reported on limb deformities related to specific local injuries and contexts, including multiple papers on war/conflict in Syria, Myanmar, Palestine, and Afghanistan, snake bite–related sequelae in West African nations causing subsequent deformity, mycetoma-related amputations in Sudan, and oncologic-related amputations across several LICs and LMICs [14,18,23,[25], [26], [27],30,33,35,43]. Less than half of eligible studies (43%) reported on some aspect of the broader socioeconomic and collective disease burden, either at the societal level (17%) utilizing QALYs/DALYs [8,20,33] or at the individual level focused on the impact of the limb deformity on the affected individual’s employment/occupation (33%) [15,16,25,30,45], patient-reported or clinician-assessed functional outcomes (33%) [15,17,19,30,42], psychological/interpersonal impact (44%) [19,[23], [24], [25],30,42,45], and/or access to care (17%) using surveys and/or interviews [18,19,40]. Nine studies provided no breakdown of the prevalence or incidence of specific diagnoses, with the remaining studies providing only partial data. Of the limited data available, clubfoot was the most commonly documented condition with 24,741 cases, followed by post-infectious deformity (n = 7179) inclusive of gangrene, poliomyelitis, chronic ulcers and mycetoma, gluteal fibrosis (n = 2759) and post-traumatic deformities (n = 707). Other conditions documented include angular knee deformity (n = 181), pes planus (n = 145), MSK tumors such as Ewing sarcoma and osteosarcoma (n = 131), postinjection paralysis (n = 1243), femoral head necrosis (n = 61), rickets (n = 42), Blount’s disease (n = 22), and genu valgum (n = 5). There was one reported case each of tibial hemimelia, osteogenesis imperfecta, arthrogryposis multiplex, hemihypertrophy, and pes cavus. Discussion Despite the high overall burden of MSK conditions in LICs and LMICs, there is a dearth of granular epidemiological data on the burden of disease of infectious, traumatic, congenital, nutritional, and oncologically acquired lower limb deformities. Utilizing a standardized approach, we identified 42 relevant studies over a decade, many restricted in scope to a single geographic area and focused solely on individual hospitals or treatment centers. The most common study design was a cross-sectional (45%) survey, though these often lacked detailed epidemiologic information enabling calculation of the estimated prevalence of the deformity in the local, national, or regional context. Due to such limitations and the heterogeneity of available information, we were not able to perform any subsequent higher-level analyses aimed at estimating the population-wide prevalence of lower limb deformities in LIC/LMIC nations. The data were also too variable and incomplete to quantify the burden of such deformities in a standardized manner across countries by calculating QALYs or DALYs. For comparative context on data collection on LLDs elsewhere, in HICs, there exists a more robust data collection and sharing infrastructure between health care facilities and governmental and research institutions [50,51]. Examining routes for epidemiologic data collection, etiologies like congenital deformities are commonly reported by health care facilities for inclusion in state- and national-level datasets. In the United States, while there is no national-level database, most states have local surveillance systems of monitoring, and ten states have Centers for Disesase Control (CDC) funded population-level surveillance and reporting of congenital birth deformities [52]. In Europe, the European network of population-based registries for the epidemiological surveillance of congenital anomolies (EUROCAT) is a network of population-based registries that conducts epidemiologic surveillance of congenital anomalies and surveys over 1.7 million births per year across 21 European countries using 38 multiple-source registries [53]. The same registries and data-sharing networks in higher-income nations cannot easily be identically duplicated for implementation in LICs and LMICs due to resource limitations and more variable access to care among the population [54]. Partnership and collaboration among stakeholders in LICs and LMICs, such as local hospitals, governments, and international governmental and nongovernmental organizations (NGOs), can help build such an infrastructure. While NGOs, donors, and HIC academic partners often provide academic support, funding, and material supplies for LICs and LMICs, partnership with the local government and public health sector is necessary to lend credibility, sustainability, and facilitate longitudinal data collection and capacity building to create an integrated data reporting and sharing infrastructure. While there were some issues with long-term viability, the work done on clubfoot in Uganda serves as an informative case study for building such partnerships in LICs and LMICs. The Uganda Sustainable Clubfoot Care Project initially involved the Canadian International Development Agency partnering with the Ugandan Ministry of Health, local medical and training schools, and international clubfoot aid organizations in implementing a public awareness and standardized screening and treatment initiative addressing clubfoot. Unfortunately, clubfoot care declined after the program transitioned from external funding to government support due to difficulties with integration into the health care system and financial sustainability. In 2017, the program was revitalized as the National Clubfoot Program of Uganda, maintaining a similar structure to its predecessor with a memorandum of understanding between the Ministry of Health, an international NGO, and a local implementing partner. This partnership enabled the estimation of the incidence of clubfoot in Uganda as 1.2 per 1,000 live births as of 2009 and to increase access to clubfoot care for many children in the country. It provided insights into local perceptions of clubfoot barriers to treatment adherence and outcomes [55,56]. Forty-three percent of included studies addressed the disease burden of lower limb deformities by assessing the impact on an individual level. Though these data are limited due to variable methodologies and the population surveyed, it is a potent indicator of the need to further investigate the burden of lower limb deformities via impact on the affected individual’s mental and physical health, ability to work, and financial stability. Included data revealed that in cases where amputations were performed, such as in extensive MSK tumors or following trauma or infection, many patients refused surgery or delayed seeking care, perhaps due to the stigma faced by amputees. In Sierra Leone, for example, those with amputations reported being ostracized by family and community due to being seen as burdensome to family members, with some traditional beliefs espousing that disabilities stem from witchcraft and that disabled individuals are devils in human bodies [45]. For some patients, such stigmas associated with amputations and limb deformities impacted their care seeking, with some oncologic cases not presenting until their cancer had progressed to an advanced stage with limited treatment options available in an austere environment [23]. Other potential reasons for delay in seeking care for lower limb deformities included prohibitive cost burden, distance to health centers, lack of awareness about the condition, and lack of trust in the health care system [28,40]. For recurrent conditions such as mycetoma, some authors described similar aforementioned barriers to care, in addition to presentations following the initial procedures by inexperienced providers or traditional bonesetters, resulting in more severe deformities upon presentation [36]. Among amputees, some authors reported that the unavailability of affordable limb prostheses and lack of appropriate physical therapy and rehabilitative resources led to an over-reliance on mobility devices like manual wheelchairs, which were also in short supply and over time limited such patients from recovering to their baseline or achieving their new maximal ambulatory functional status [15,16,24,25,29,44]. Among patients who suffered traumatic amputations due to blast injuries, many of whom were children or young adults and were previously attending school or employed, lack of occupational therapy prohibited their return to school or work, resulting in current or future unemployment and ultimately contributing to generational poverty [16,43]. Consequently, amputation was noted to adversely affect the quality of life in this population, with poor mental health outcomes and a sense of loss of dignity [25,29,45]. Some authors suggested that in addition to adequate and quality rehabilitative support, prosthetic and orthotic users may need direct financial support to help them meet their basic needs [24,25,30]. Likewise, children with congenital deformities such as clubfoot who were untreated or undertreated went on to experience lifelong and limiting disability [21]. Similarly, adults with severe, debilitating MSK injuries in austere environments were at times bedbound and unable to perform activities of daily living, resulting in a significant financial and social burden for their families [19,24]. Understanding the scope of barriers to care faced by this diverse population with lower limb deformities in resource-limited environments through well-designed epidemiologic studies is paramount to quantifying the burden of disease. Such relevant data can then inform increasing access and providing local resources to improve the timeliness and accuracy of diagnoses, build appropriate surgical and rehabilitative capacity, reduce stigma around conditions such as amputations through education, and provide socioeconomic support services for those living in resource-limited environments. Data collection related to deformity and disability remains a significant challenge globally, particularly in LICs and LMICs. Barriers include a lack of shared terminology and standardized measurements, inadequate data sharing across government bodies and relevant organizations, and concerns about adequate funding and system capacity to accommodate detailed information on deformity types, functional limitations, and access to services. While PROs are important, their broader applicability is limited due to limited validation across conditions, geographic locations, and languages. A potential starting point could involve incorporating cost-effective yet pertinent measures, such as the Washington Group on Disability Statistics short set of six questions, which align with standardized International Classification of Functioning, Disability and Health–based functioning into existing census surveys and data collection instruments [57]. Most studies (57%) included in our review did not include such data, indicating a gap that can be filled by expanding the study design and lenses of inquiry through which researchers report patients’ experiences with lower limb deformities. Limitations to our study included language restriction, as only English-language publications were included, risking missing relevant information published in other languages. Our search solely included publications in academic journals, inevitably failing to capture data published via other routes including governmental briefings, press releases, or raw data sets. Additionally, there was a lack of explicit inclusion of oncology-specific terms in our search strategy. While our search terms included concepts related to orthopaedic oncology, such as “amputation” and “deformity,” we did not specifically target oncologic conditions in our query or Medical Subject Headings terms. As a result, relevant oncology-related articles may have been under-represented, and the breadth of ortho-oncologic findings in LICs and LMICs might not have been fully captured. Future studies could address this limitation by explicitly incorporating oncology-specific terms. Due to the quantity of publications screened and time required for screening and subsequent data analysis, we were unable to include publications in subsequent years (2023–2025) and so are unable to capture publications from that time period. Ultimately, our search resulted in only 42 studies screened over the decade (2012–2022) for inclusion, a telling number demonstrating the research gap in this area. This absence of detailed information inherently limited the scope of our analysis and our ability to broaden the discussion by attempting to include informed estimates on the epidemiology of the different lower limb deformities or their impact on the cost to the health care system, individuals, or DALYs. Conclusions Limited surveillance and reporting infrastructures, especially in LICs and LMICs, have a downstream effect on our ability to study the overall prevalence and the physical, psychosocial, and economic impact of MSK conditions like lower limb deformities on affected individuals, their families, and their communities. To enhance our understanding of the epidemiology and burden of lower limb deformities in austere environments, creative partnerships between local and national health authorities, academic institutions, NGOs, and international partners can create routes for building more robust, locally relevant, and sustainable infrastructures such as making a centralized data repository for lower limb deformities. A better understanding of the epidemiology of these deformities will allow for more tailored preventative education campaigns, enhance appropriate access to care, and facilitate timely diagnosis and treatment of such MSK conditions. Additional links •JPOSNA®: Essentials of Pediatric Prosthetics•POSNA Study Guide: Clubfoot•POSNA Resident Review: 5 Tips on Preoperative Planning for Lower Extremity Deformity Correction •JPOSNA®: Essentials of Pediatric Prosthetics JPOSNA®: Essentials of Pediatric Prosthetics •POSNA Study Guide: Clubfoot POSNA Study Guide: Clubfoot •POSNA Resident Review: 5 Tips on Preoperative Planning for Lower Extremity Deformity Correction POSNA Resident Review: 5 Tips on Preoperative Planning for Lower Extremity Deformity Correction Author contributions Rachel L. Montoya: Writing – review & editing, Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Kehinde S. Agoro: Writing – review & editing, Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Riasoya Jodah: Writing – review & editing, Writing – original draft, Visualization, Investigation, Formal analysis. Sanjeev Sabharwal: Writing – review & editing, Supervision, Methodology, Data curation, Conceptualization. Coleen S. Sabatini: Writing – review & editing, Supervision, Methodology, Investigation, Data curation, Conceptualization. Ethics approval and consent The author(s) declare that no patient consent was necessary as no images or identifying information is included in the article. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.